Article

Binkhorst Lecture focuses on improving safety, efficacy in phaco

Washington, DC &#8212 Cataract surgery has improved in terms of safety and efficacy with the introduction of phacoemulsification, foldable IOLs, and the use of smaller incisions.

April 17 - Washington, DC - Cataract surgery has improved in terms of safety and efficacy with the introduction of phacoemulsification, foldable IOLs, and the use of smaller incisions. With a better understanding of fluidics - infusion and aspiration - phacoemulsification will continue to be refined.

Graham D. Barrett, MD, who delivered the Binkhorst Lecture during the opening session of the American Society of Cataract and Refractive Surgery annual meeting, explained that he became interested in the underlying mechanisms of phacoemulsification, which improved safety and efficacy, and therefore focused on this aspect of cataract surgery for this year's lecture.

In the 1980s, when he began practicing cataract surgery, the recommended incision size was 3.2 mm, which could lead to wound leakage, impaired chamber stability, and an increased the risk of rupture of the posterior chamber.

"This experience lead me to an appreciation of the important role of fluid infusion, phaco needles, pump systems, surgical technique, and aspiration tubing in achieving a balance between aspiration and infusion, which is fundamental in improving safety and efficacy in phacoemulsification," said Dr. Barrett, a consultant ophthalmologist in private practice, Lions Eye Institute, and head, department of ophthalmology, Sir Charles Gairdner Hospital, Nedlands, Western Australia.

He has developed various instruments to aid the cataract surgeon, including a new phaco needle that allows for a 2.6-mm wound with improved infusion, which reduces the chance of wound burn. He also designed an I/A cannula to help remove cortical material. The device, he explained, has a greater cross-sectional area, which improves the infusional fluid and also reduces surge during aspiration of cortical material.

Dr. Barrett noted that although improved technology has been critical in patient outcomes, surgeon techniques are also important in the drive for safety and efficacy. He covered ways to subdivide the nucleus as well as modifying aspiration tubing to prevent surge. He developed flow adaptive tubing to allow for higher vacuum levels and decreased risk of surge.

He also described some prototypes of instruments to be used in micro-incision cataract surgery. They included a coaxial irrigating device with sleeve diameter of 1.2 mm, a solid core needle with a titanium sleeve (able to deliver ultrasonic energy at the tip), and a solid core needle with a hollow tip and a plastic sleeve.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.